With our broad range of experience and deep expertise, we have the talent, technologies and scale to serve markets throughout the world. This is backed by 5 of our state-of-the-art facilities that provide end-to-end services from R&D to clinical to commercial.
Industrial Park Facility
Features: R&D center, Analytical Center, Clinical & Commercial scale manufacturing, cGMP Manufacturing, Non-GMP manufacturing, Advanced Controlled Release Technologies, Tablets & Capsules, Manufacturing Permit for DEA Schedules I-IV, Packaging & Distribution.
Size: 138,000 ft2
West Coast Facility
Features: Expanded R&D Capabilities, Expanded Analytical Capabilities, Clinical & Commercial scale manufacturing, cGMP Manufacturing, Non-GMP manufacturing, Advanced Controlled, Release Technologies, Softgels, Liquids & Suspensions, Packaging & Distribution.
Size: 300,000 ft2
Our state-of-the-art global R&D centers specialize in small molecule development across all dosage forms, including oral solids, injectables, topicals, inhalation products, and complex delivery systems. We leverage advanced technologies such as lyophilization, spray drying, hot-melt extrusion, nanomilling, fluid bed processing, amorphous solid dispersions, microencapsulation, and lipid-based delivery systems to tackle challenges like bioavailability enhancement, controlled release, stability, and targeted delivery.